Meritage Group’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,180	Closed	-$322K	–	24
2024 Q2	$322K	Buy	1,180 +424	+56%	+$123K	0.01%	28
2024 Q1	$261K	Sell	756 -61	-7%	-$20.1K	0.01%	47
2023 Q4	$264K	Buy	+817	New	+$256K	0.01%	41
2023 Q3	–	Sell	-753	Closed	-$285K	–	54
2023 Q2	$285K	Buy	+753	New	+$306K	0.01%	27
2022 Q3	–	Sell	-469	Closed	-$232K	–	39
2022 Q2	$232K	Sell	469 -324	-41%	-$169K	0.01%	28
2022 Q1	$447K	Sell	793 -229	-22%	-$138K	0.01%	19
2021 Q4	$772K	Buy	1,022 +566	+124%	+$424K	0.02%	18
2021 Q3	$340K	Sell	456 -415	-48%	-$311K	0.01%	25
2021 Q2	$561K	Buy	871 +142	+19%	+$86.4K	0.01%	17
2021 Q1	$416K	Buy	729 +57	+8%	+$33.8K	0.01%	21
2020 Q4	$392K	Sell	672 -89	-12%	-$50.7K	0.01%	25
2020 Q3	$392K	Buy	+761	New	+$385K	0.01%	22